Darvoni 60 mg+400 mg tablet
Generic: Daclatasvir + Sofosbuvir
Company: Beacon Pharmaceuticals PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated August 13, 2025.
Generic: Daclatasvir + Sofosbuvir
Company: Beacon Pharmaceuticals PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated August 13, 2025.
Sorted by price per tablet. Ask your pharmacist before you switch brands.
Prices as listed on BestinMeds.
Advertisement
What this medicine is for, how to take it, and what to watch for.
Read the full Daclatasvir + Sofosbuvir guide
Direct acting antiviral agent (DAA) against the hepatitis C virus Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying. And Daclatasvir is a direct-acting antiviral agent (DAA) against the hepatitis C virus.
This information is not available. Ask your doctor or pharmacist.
This information is not available. Ask your doctor or pharmacist.
This information is not available. Ask your doctor or pharmacist.
This information is not available. Ask your doctor or pharmacist.
Sofosbuvir is an inhibitor of the hepatitis C virus (HCV) NS5B ribonucleic acid (RNA)-dependent RNA polymerase, which is essential for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. In a biochemical assay, GS-461203 inhibited the polymerase activity of the recombinant NS5B from HCV genotype 1b, 2a, 3a and 4a with a 50% inhibitory concentration (IC50) value ranging from 0.7-2.6 micrometer. GS-461203 (the active metabolite of sofosbuvir) is not an inhibitor of human deoxyribonucleic acid (DNA) and RNA polymerases, nor an inhibitor of mitochondrial RNA polymerase. Daclatasvir stops HCV viral RNA replication and protein translation by directly inhibiting HCV protein NS5A. NS5A is critical for HCV viral transcription and translation.
This information is not available. Ask your doctor or pharmacist.
This information is not available. Ask your doctor or pharmacist.
This information is not available. Ask your doctor or pharmacist.
Hepatic viral infections (Hepatitis C)
This information is not available. Ask your doctor or pharmacist.
BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.
Advertisement
No other Darvoni products are listed yet.
Advertisement